Thomas Jefferson University at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Thomas Jefferson University brings 17 presentations to ASH 2026 in New Orleans. Its program spans sickle cell disease, platelet function and artificial intelligence in hematology practice. It covers a GRK5 variant that enhances platelet procoagulant activity and antihypertensives in cytokine release syndrome with bispecifics.
| Organization | ASH 2026 Attendance |
|---|---|
Thomas Jefferson University Philadelphia, PA | |
Private university and academic health system in Philadelphia, Pennsylvania. | Symposium Fri Dec 11 7:00am–10:00am A Hematologist’s Guide to the Sickle Cell Disease Revolution: Genes, Activators, and Beyond Approved and emerging gene therapies and new pyruvate kinase activators for sickle cell disease, and how to match patients to each and refer them. Session Fri Dec 11 1:35pm–3:55pm Oral Sat Dec 12 2:00pm–3:30pm Oral Sat Dec 12 4:00pm–5:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Talk Sun Dec 13 11:15am–12:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 2:45pm–4:15pm Oral Mon Dec 14 4:30pm–6:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Thomas Jefferson University
Tell us what you sell and we’ll find the people at Thomas Jefferson University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction